| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14712598.2011.610788 |
| P698 | PubMed publication ID | 21877997 |
| P2093 | author name string | Elisabeth I Heath | |
| Madhuri Bajaj | |||
| P2860 | cites work | A novel receptor for Apo2L/TRAIL contains a truncated death domain | Q28255451 |
| A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera | Q30937297 | ||
| Targeting death receptors in cancer with Apo2L/TRAIL. | Q35834889 | ||
| Promoting apoptosis as a strategy for cancer drug discovery | Q36292878 | ||
| Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types | Q39740467 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | monoclonal antibody | Q422248 |
| P304 | page(s) | 1519-1524 | |
| P577 | publication date | 2011-08-31 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Expert Opinion on Biological Therapy | Q5421201 |
| P1476 | title | Conatumumab: a novel monoclonal antibody against death receptor 5 for the treatment of advanced malignancies in adults | |
| P478 | volume | 11 |
| Q36762882 | Clinical targeting of the TNF and TNFR superfamilies |
| Q36366424 | Intracellular-signaling tumor-regression modeling of the pro-apoptotic receptor agonists dulanermin and conatumumab |
| Q35876847 | Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells |
| Q33947014 | Poly(ADP-ribose) polymerase inhibitors sensitize cancer cells to death receptor-mediated apoptosis by enhancing death receptor expression. |
| Q38162939 | Small molecules as pro-apoptotic anticancer agents |
Search more.